ArticleInternational archives of otorhinolaryngology2025
Audiological Profile of Patients with Vitiligo.
Article in International archives of otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vitiligo is one of the most common causes of hypopigmentation; it occurs when melanin production is impaired due to the loss of melanocytes, which are present throughout the skin, in the epidermis, and in hair follicles, and are also seen in the mucosa, uvea, and several structures of the inner ear. Scientists have investigated the association between vitiligo and sensorineural hearing loss (SNHL); some believe there is a connection, while others disagree. Objective: To evaluate the relationship between vitiligo and SNHL. Methods: The present observational study was conducted from February 2023 to January 2024. A total of 54 patients with clinically diagnosed vitiligo were assessed for hearing impairment. Simultaneously, 50 healthy volunteers were included as a control group, and the data was analyzed to assess any potential association between vitiligo and SNHL. Results: The mean age of the control group was of 37.5(± 10) years, and that of the patients with vitiligo was of 38.8(± 11) years, and the male-to-female ratio was of 1:1. We observed SNHL in 32 (59.3%) patients with vitiligo, and those with vitiligo vulgaris were the most afflicted. The hearing loss was mild in 2 ears (3.1%), moderate in 24 (37.5%), and severe in 29 (45.3%), with 29 patients belonging to the group with high frequency hearing loss. Conclusion: Based on the findings; it is imperative that patients with vitiligo undergo routine auditory function assessments to facilitate the early detection of SNHL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.